Opexa Therapeutics (Nasdaq: OPXA) Developing MS Treatment in Partnership with Merck Serono – Video

Posted: Published on December 21st, 2014

This post was added by Dr Simmons




Opexa Therapeutics (Nasdaq: OPXA) Developing MS Treatment in Partnership with Merck Serono
Host Dave Gentry interviews Neil Warma, CEO of Opexa Therapeutics (Nasdaq: OPXA), a biotechnology company developing Tcelna, a novel T-cell immunotherapy fo...

By: Dave Gentry

See the original post:
Opexa Therapeutics (Nasdaq: OPXA) Developing MS Treatment in Partnership with Merck Serono - Video

Related Posts
This entry was posted in MS Treatment. Bookmark the permalink.

Comments are closed.